Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SIBN
SIBN logo

SIBN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy SI-BONE Inc (SIBN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.170
1 Day change
1.39%
52 Week Range
21.890
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

SI-BONE Inc (SIBN) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has positive analyst sentiment and hedge fund interest, its financial performance shows declining profitability, and technical indicators suggest a bearish trend. The stock's oversold RSI may indicate a potential rebound, but there are no strong catalysts or trading signals to justify immediate action.

Technical Analysis

The technical indicators are bearish. The MACD is negative and contracting, RSI is at 17.157 (oversold), and moving averages are in a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with S1 at 12.811 and S2 at 12.391.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
4

Positive Catalysts

  • Hedge funds are significantly increasing their positions, with a 457520.97% increase in buying over the last quarter. Analysts have raised price targets and maintained Buy ratings, citing strong revenue growth and a promising product cycle.

Neutral/Negative Catalysts

  • Gross margin also slightly declined. Technical indicators are bearish, and there are no recent news or significant trading signals to support an immediate buy.

Financial Performance

In Q4 2025, revenue increased by 14.99% YoY to $56.35M, but net income dropped by 63.43% YoY to -$1.64M. EPS also fell by 63.64% YoY to -0.04, and gross margin slightly declined to 79.03%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are positive on the stock, with Truist and TD Cowen raising price targets to $24 and $22, respectively, and maintaining Buy ratings. Analysts highlight strong revenue growth, gross margin upside, and a promising product cycle as key factors for their optimism.

Wall Street analysts forecast SIBN stock price to rise
6 Analyst Rating
Wall Street analysts forecast SIBN stock price to rise
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 13.170
sliders
Low
23
Averages
25.17
High
28
Current: 13.170
sliders
Low
23
Averages
25.17
High
28
Truist
Buy
maintain
$23 -> $24
AI Analysis
2026-02-24
Reason
Truist
Price Target
$23 -> $24
AI Analysis
2026-02-24
maintain
Buy
Reason
Truist raised the firm's price target on SI-Bone to $24 from $23 and keeps a Buy rating on the shares after its Q4 earnings beat. The company complemented its pre-announced revenue beat with gross margin upside and adjusted EBITDA about $3M ahead of consensus, while its 2026 guidance brackets estimates and should be viewed as a solid jumping-off point, the analyst tells investors in a research note.
TD Cowen
Buy
maintain
$21 -> $22
2026-02-24
Reason
TD Cowen
Price Target
$21 -> $22
2026-02-24
maintain
Buy
Reason
TD Cowen raised the firm's price target on SI-Bone to $22 from $21 and keeps a Buy rating on the shares. The firm said the company is set up well for 2026 with underlying momentum and a new product cycle set to come.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SIBN
Unlock Now

People Also Watch